Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...
3P and Buzzard Pharmaceuticals Enter Cancer Collaboration
3P Biopharmaceuticals (3P), a Contract Development and Manufacturing Organization (CDMO) specialized in the process development and GMP manufacturing of biologics, and Buzzard Pharmaceuticals (Buzzard),...
New mineral improves probiotic stability
Swiss manufacturer Omya is developing a new mineral solution for greater stability, performance and survival rates of probiotics during formulation and delivery to the...
CPhI Discover: pharma grows through partnering
The last year has been a hugely exiting time for pharma with the industry taking centre stage globally. It’s been a remarkable year of...
CPhI post-pandemic executive pharma survey: COVID-19 driving manufacturing and CDMOs driving growth
Ahead of CPhI Discover (17th-28th May, 2021) – global pharma’s largest ever virtual gathering – the CPhI executive post-pandemic pharma survey predicts that pandemic...
US Allows Johnson & Johnson Covid Vaccination To Resume
Johnson & Johnson Covid vaccinations can restart, US health regulators said Friday, after the shots' rollout was paused due to worries over blood clotting.
Health...
Lonza Announces Construction of a New Small Molecule Manufacturing Complex in Visp
Lonza, a CDMO partner to the biopharma industry, announced the construction of a new small molecule manufacturing complex at its Visp (CH) site. The...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...